In her career as a researcher, Sharon Anderson has expanded understanding of the pathophysiology of diabetic nephropathy (one of the leading causes of chronic kidney disease (CKD) and end-stage renal disease (ESRD) globally), and has uncovered the important effect of ACE inhibitors in modifying the progression of diabetic nephropathy.
In her career as a researcher, Sharon Anderson has expanded understanding of the pathophysiology of diabetic nephropathy (one of the leading causes of chronic kidney disease (CKD) and end-stage renal disease (ESRD) globally), and has uncovered the important effect of ACE inhibitors in modifying the progression of diabetic nephropathy.